| P50 | author | Toshiyuki Matsui | Q91840624 |
| | Toshifumi Hibi | Q91933653 |
| | Mamoru Watanabe | Q110728734 |
| | Takayuki Matsumoto | Q110729448 |
| | Masakazu Takazoe | Q117217196 |
| | Satoshi Motoya | Q117217198 |
| P2860 | cites work | Inflammatory Bowel Disease | Q22248115 |
| | Sargramostim for active Crohn's disease | Q28252940 |
| | Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor | Q28290896 |
| | Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer | Q33497695 |
| | Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease | Q33956828 |
| | The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review | Q34521232 |
| | GM-CSF treatment for Crohn's disease: a stimulating new therapy? | Q35032847 |
| | Identification of GM-CSF in Paneth cells using single-cell RT-PCR. | Q44677525 |
| | An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease | Q45264286 |
| | Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation | Q71793153 |
| | Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant | Q74350077 |
| | Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor | Q78519010 |
| P433 | issue | 6 | |
| P921 | main subject | Crohn's disease | Q1472 |
| | sargramostim | Q3950557 |
| P304 | page(s) | 535-543 | |
| P577 | publication date | 2009-04-08 | |
| P1433 | published in | Journal of Gastroenterology | Q15764399 |
| P1476 | title | Sargramostim in patients with Crohn's disease: results of a phase 1-2 study | |
| P478 | volume | 44 | |